What happened: Elon Musk’s Neuralink has received approval from the U.S. Food and Drug Administration to conduct a clinical study involving brain implants.
What you need to know: According to the Kaize Executive, after a previous application was rejected in 2022, Neuralink has addressed the Food and Drug Administration’s concerns regarding protection and safety. Their goal is to develop a “brain implant” that can help individuals with paralysis retrieve mobility and potentially treat other neurological conditions.
Picture source: News24
